The DOI matches its Crossref record; 9 of the 9 references it cites were found in a registry or an index.
Potassium Cyanate as an Inhibitor of the Sickling of Erythrocytes In Vitro
Open accessAbstract
The recent use of urea as a treatment for the crisis phase of sickle-cell anemia has prompted us to investigate the possibility that cyanate, which is in equilibrium with urea in solution, might itself prevent the sickling of erythrocytes. We have found that in contrast to the high concentration of urea (1 M) needed to prevent reversibly the in vitro sickling of 80% of the cells, potassium cyanate (0.01-0.10 M) irreversibly inhibits sickling to the same extent. The prevention of sickling is a function of the amount of [ 14 C]cyanate incorporated into acidprecipitable protein (0.1-1.0 mol of cyanate per mol of hemoglobin). Most of the radioactivity is accounted for by carbamylation of the NH 2 -terminal valine residues of hemoglobin; there is no detectable carbamylation of the lysine or cysteine residues. The reactive species, HN=C=O (isocyanic acid), may be an analog of O=C=O since both compounds bind to the same valine residues of hemoglobin. Deoxygenated sickled cells also incorporate [ 14 C]-cyanate, but the sickling is not reversed. Oxygenation results in normal morphology in 75% of these cells. Upon subsequent deoxygenation, these cells remain normal. Potassium cyanate (5 mM) was also found to be an effective inhibitor of the gelling of deoxyhemoglobin S.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
DISC ELECTROPHORESIS – II METHOD AND APPLICATION TO HUMAN SERUM PROTEINS*
Davis, B. J. (1964) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1964.tb14213.x · Cited by 18,892
PLAQUE FORMATION AND ISOLATION OF PURE LINES WITH POLIOMYELITIS VIRUSES
Dulbecco, R., & Vogt, M. (1954) · Journal of Experimental Medicine · doi:10.1084/jem.99.2.167 · Cited by 3,824
Molecular Pathology of Human Haemoglobin
PERUTZ, M. F., & LEHMANN, H. (1968) · Nature · doi:10.1038/219902a0 · Cited by 574
The Use of Cyanate for the Determination of NH2-terminal Residues in Proteins
Stark, G. R., & Smyth, D. G. (1963) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)83983-2 · Cited by 474
Murayama, M. (1966) · Science · doi:10.1126/science.153.3732.145 · Cited by 204
Harris, J. W. (1950) · Experimental Biology and Medicine · doi:10.3181/00379727-75-18144 · Cited by 190
Properties of sickle-cell haemoglobin
ALLISON, A. C. (1957) · Biochemical Journal · doi:10.1042/bj0650212 · Cited by 137
Determination of cyanate, and a study of its accumulation in aqueous solutions of urea
Marier, J. R., & Rose, D. (1964) · Analytical Biochemistry · doi:10.1016/0003-2697(64)90135-6 · Cited by 97
TITRATABLE SULFHYDRYL GROUPS OF NORMAL AND SICKLE CELL HEMOGLOBINS AT 0° AND 38°
Murayama, M. (1957) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(18)70705-9 · Cited by 67
Cited by
Pathogenesis and Treatment of Sickle Cell Disease
Bunn, H. F. (1997) · New England Journal of Medicine · doi:10.1056/nejm199709113371107 · Cited by 1,154
Riess, J. G. (2001) · Chemical Reviews · doi:10.1021/cr970143c · Cited by 773
X-ray Diffraction Study of Binding of 2,3-Diphosphoglycerate to Human Deoxyhaemoglobin
ARNONE, A. (1972) · Nature · doi:10.1038/237146a0 · Cited by 739
Sickle cell pain: a critical reappraisal
Ballas, S. K., Gupta, K., & Adams-Graves, P. (2012) · Blood · doi:10.1182/blood-2012-04-383430 · Cited by 445
Quaternary Structure of Proteins
Klotz, I. M., Langebman, N. R., & Dahnall, D. W. (1970) · Annual Review of Biochemistry · doi:10.1146/annurev.bi.39.070170.000325 · Cited by 298
Erythrocytic mechanism of sickle cell resistance to malaria.
Friedman, M. J. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.4.1994 · Cited by 297
Hemoglobin Carbamylation in Uremia
Flückiger, R., Harmon, W., Meier, W., Loo, S., & Gabbay, K. H. (1981) · New England Journal of Medicine · doi:10.1056/nejm198104023041406 · Cited by 262
Emerging genetic therapy for sickle cell disease
Orkin, S. H., & Bauer, D. E. (2019) · Annual Review of Medicine · doi:10.1146/annurev-med-041817-125507 · Cited by 119
Metadata
- Authors
- Cerami, A., & Manning, J. M.
- Venue
- Proceedings of the National Academy of Sciences
- Published
- 1971-06
- Volume
- 68
- Issue
- 6
- Pages
- 1180-1183
- ISSN
- 0027-8424 (ISSN-L)
- 1091-6490
- OpenAlex
- W2018875508
- Cited by
- 255
- References
- 9
- FWCI
- 44.31
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.